No Data
Amita Holdings: Supplementary financial results for the 3rd quarter of the fiscal year ending 2024/12
Amita Holdings: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Amita Holdings 9-Mos Net Y277.00M Vs Net Y144.00M
Daiwa House, Idemitsu Kosan, Tokyo Electron Ltd. unsponsored adr, SoftBank Group (12th)
※Please note that the above calendar is subject to change depending on the company's circumstances. --------------------------------------- November 12 (Tuesday) ＜1431＞ Livework ＜146A＞ Colombia ＜148A＞ Hatchwork ＜1491＞ Chugai Mining ＜1605＞ INPEX ＜1663＞ K&O Energy ＜166A＞ Taski HD ＜1770＞ Fujita E
Cocolara, OncoList Bio, and others.
<2195> Amita HD absorbs and merges a complete subsidiary MIDAO <3907> Silicon Studio downward revision, current fiscal year operating profit outlook 14.8 billion yen ← 25.4 billion yen <4176> Kokonara upward revision, previous fiscal year operating profit outlook 30.4 billion yen ← 27 billion yen <4563> Angel's gene therapy product "Collategene" designated breakthrough therapy for effects <4588> Oncolis Bio 20th new subscription rights (with exercise price revision clause) massive exercise from the 1st onwards.
Alps Al, Mitsui Chemicals, etc.
*AlpsAlp <6770> autos software advancement, business opportunity in SDV, 7 billion yen investment (Nikkan Kogyo front page) - ○ * NTT <9432> NTT Communications, Mirai Sense and tactile sensation, transmission verification with IOWN (Nikkan Kogyo page 3) - ○ * Mitsui Chemicals <4183> Idemitsu Kosan, consolidation of ethylene facilities in Chiba, starting basic design (Nikkan Kogyo page 3) - ○ * 7&iHD <3382> Major convenience store chain, increases acquisition to 7 trillion yen, aims for negotiation (Nikkan Kogyo page 3) - ○ * Nagase Sangyo <8012>
No Data
No Data